What does PHARMACIE MERCURE do?

PHARMACIE MERCURE is a pharmacy in Jette. Public Limited, started on 24 June 1987, 1 establishment.

What is the address of PHARMACIE MERCURE?

The registered office of PHARMACIE MERCURE is located at Henri Liebrechtlaan 76, 1090 Jette.

Is PHARMACIE MERCURE still active?

Yes. According to the CBE (29 October 2026) PHARMACIE MERCURE is active, legal situation “Normale toestand”, started on 24 June 1987.

Is PHARMACIE MERCURE registered on Peppol?

Yes, PHARMACIE MERCURE is registered on the Peppol network with ID 0208:0431511329.

What is the enterprise number of PHARMACIE MERCURE?

The enterprise number of PHARMACIE MERCURE is BE0431511329.

When was PHARMACIE MERCURE founded?

PHARMACIE MERCURE was founded on 24 June 1987.

Who are the directors of PHARMACIE MERCURE?

According to the 2025 annual accounts, the directors of PHARMACIE MERCURE are: MEDITRINE SRL.

Is PHARMACIE MERCURE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 June 1987; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE MERCURE make in 2025?

PHARMACIE MERCURE recorded a loss after taxes of € 163,899 in financial year 2025.

What is the revenue of PHARMACIE MERCURE?

As a small company, PHARMACIE MERCURE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 523,956.

How much does an employee at PHARMACIE MERCURE earn?

The average wage cost per full-time employee at PHARMACIE MERCURE was € 87,300 in 2025: staff costs of € 401,465 for 4.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE MERCURE have?

According to the 2025 annual accounts, PHARMACIE MERCURE has 4.6 full-time equivalents (FTE).

PHARMACIE MERCURE (Public Limited) - Jette - BE0431511329

Dossier PHARMACIE MERCURE, printed on 29 October 2026 from databakkes.be/en/0431511329/pharmacie-mercure. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 46 % of short-term debt in 2025; threshold 65 %.
Figures corrected NBB

Corrected annual account filed for 2022.
Busy address KBO

17 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

PHARMACIE MERCURE from Jette, company number BE0431511329, closed financial year 2025 with a result of € -163,899 after tax. For that financial year PHARMACIE MERCURE recorded a gross margin of € 523,956 and equity of € 315,164. Compared with financial year 2024, the result moved from € 11,772 to € -163,899. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Healthy

€ 315,164

▼ 32% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -163,899

▼ still € 11,772 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 87,528

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 184,536.

People and assets in 2025

Full-time equivalents

4.6

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 401,465

▲ 12% vs 2024

€ 87,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 587,205

▼ 13% vs 2024

Of which on lease € 103,745.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 577,697

▼ 10% vs 2024

€ 63,521 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 313,617

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 53,886

▲ 29% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 342,513 Gross margin 2022: € 342,513 First fiscal year in the series	€ 399,238 Gross margin 2023: € 399,238 ▲ 17% vs 2022 (€ 342,513) Favourable step	€ 469,680 Gross margin 2024: € 469,680 ▲ 18% vs 2023 (€ 399,238) Favourable step	€ 523,956 Gross margin 2025: € 523,956 ▲ 12% vs 2024 (€ 469,680) Favourable step	▲ 12%
Profit after taxes	€ 23,830 Profit after taxes 2022: € 23,830 First fiscal year in the series	€ 33,071 Profit after taxes 2023: € 33,071 ▲ 39% vs 2022 (€ 23,830) Favourable step	€ 11,772 Profit after taxes 2024: € 11,772 ▼ 64% vs 2023 (€ 33,071) Unfavourable step	€ -163,899 Profit after taxes 2025: € -163,899 ▼ € 175,671 vs 2024 (€ 11,772) Unfavourable step	▼ € 175,671
Equity	€ 421,592 Equity 2022: € 421,592 First fiscal year in the series	€ 454,663 Equity 2023: € 454,663 ▲ 8% vs 2022 (€ 421,592) Favourable step	€ 466,435 Equity 2024: € 466,435 ▲ 3% vs 2023 (€ 454,663) Favourable step	€ 315,164 Equity 2025: € 315,164 ▼ 32% vs 2024 (€ 466,435) Unfavourable step	▼ 32%
Total debts	€ 878,544 Total debts 2022: € 878,544 First fiscal year in the series	€ 906,976 Total debts 2023: € 906,976 ▲ 3% vs 2022 (€ 878,544) Unfavourable step	€ 1,093,688 Total debts 2024: € 1,093,688 ▲ 21% vs 2023 (€ 906,976) Unfavourable step	€ 1,053,895 Total debts 2025: € 1,053,895 ▼ 4% vs 2024 (€ 1,093,688) Favourable step	▼ 4%
Cash	€ 98,103 Cash 2022: € 98,103 First fiscal year in the series	€ 156,455 Cash 2023: € 156,455 ▲ 59% vs 2022 (€ 98,103) Favourable step	€ 74,295 Cash 2024: € 74,295 ▼ 53% vs 2023 (€ 156,455) Unfavourable step	€ 87,528 Cash 2025: € 87,528 ▲ 18% vs 2024 (€ 74,295) Favourable step	▲ 18%
Retained profit	€ 359,592 Retained profit 2022: € 359,592 First fiscal year in the series	€ 392,663 Retained profit 2023: € 392,663 ▲ 9% vs 2022 (€ 359,592) Favourable step	€ 404,435 Retained profit 2024: € 404,435 ▲ 3% vs 2023 (€ 392,663) Favourable step	€ 184,536 Retained profit 2025: € 184,536 ▼ 54% vs 2024 (€ 404,435) Unfavourable step	▼ 54%
Bank debt	€ 75,000 Bank debt 2022: € 75,000 First fiscal year in the series	€ 575,000 Bank debt 2023: € 575,000 ▲ € 500,000 vs 2022 (€ 75,000) Unfavourable step	€ 638,604 Bank debt 2024: € 638,604 ▲ 11% vs 2023 (€ 575,000) Unfavourable step	€ 577,697 Bank debt 2025: € 577,697 ▼ 10% vs 2024 (€ 638,604) Favourable step	▼ 10%
Balance sheet total	€ 1,300,136 Balance sheet total 2022: € 1,300,136 First fiscal year in the series	€ 1,361,640 Balance sheet total 2023: € 1,361,640 ▲ 5% vs 2022 (€ 1,300,136) Unchanged	€ 1,560,123 Balance sheet total 2024: € 1,560,123 ▲ 15% vs 2023 (€ 1,361,640) Unchanged	€ 1,369,060 Balance sheet total 2025: € 1,369,060 ▼ 12% vs 2024 (€ 1,560,123) Unchanged	▼ 12%
Employees (FTE)	4.5 Employees (FTE) 2022: 4.5 First fiscal year in the series	4.3 Employees (FTE) 2023: 4.3 ▼ 0.2 vs 2022 (4.5) Unchanged	4.5 Employees (FTE) 2024: 4.5 ▲ 0.2 vs 2023 (4.3) Unchanged	4.6 Employees (FTE) 2025: 4.6 ▲ 0.1 vs 2024 (4.5) Unchanged	▲ 0.1

Key figures of PHARMACIE MERCURE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE MERCURE?

What happened at PHARMACIE MERCURE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: loss of € 163,899 (▼ € 175,671 vs 2024). Source: NBB ↗
2022 MEDITRINE SRL became a director. NBB
Jul 29, 1987 New establishment in Jette. KBO
Jun 24, 1987 Start of the company according to the CBE. KBO

In short

From € 23,830 profit in 2022 to € 163,899 loss in 2025.

Best year ever: 2023, with € 33,071 profit.

On average € 113,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

BELCO-PHARM 100%

MEDITRINE 100%

The stake of BELCO-PHARM, MEDITRINE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE MERCURE

Behind PHARMACIE MERCURE is MEDITRINE SRL. The shares are held by BELCO-PHARM (100%) and MEDITRINE (100%).

Directors

According to the 2025 annual accounts

MEDITRINE SRL

Director

since 2022

Shareholders

BELCO-PHARM

100%

MEDITRINE

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Henri Liebrechtlaan 76

1090 Jette

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.

All companies at this address →

OFFICE DE GESTION IMMOBILIERE, SYNDIC DE COPROPRIETES

€ 230,429 gross margin · 2025

SOLO TU

YACA

S.M.J. FRAME PRODUCTION

LECLAIRE

€ 52,859 gross margin · 2025

+12 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0431.511.329

VAT number

BE 0431.511.329

Registered office

Henri Liebrechtlaan 76, 1090 Jette

Names & denominations

PHARMACIE MERCURE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

24 June 1987

Peppol

Active · Active since 9 Oct 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE MERCURE

Warning lights

Financials

What happened to PHARMACIE MERCURE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions